1. Alexanian, R., Barlogie, B., and Dixon, D. (1986). High-dose glucocorticoid treatment of resistant myeloma. Ann. Intern. Med. 105, 8–11.
2. American Medical Association (1980). Adrenal corticosteroids. In AMA drug evaluations, 4th ed. (prepared by the AMA department of drugs), pp. 619–655. John Wiley and Sons, New York.
3. Arya, S. K., Wong-Staal, F., and Gallo, R. C. (1984). Dexamethasone mediated inhibition of human T-cell growth factor and gamma-interferon messenger RNA. J. Immunol. 133, 273–276.
4. Baus, E., Andris, F., Dubois, P. M., Urbain, J., and Leo, O. (1996). Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J. Immunol. 156, 4555–4561.
5. Boumpas, D. T., Anastassiou, E. D., Older, S. A., Tsokos, G. C., Nelson, D. L., and Balow, J. E. (1991). Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87, 1739–1747.